These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24175212)

  • 1. Molecular and clinical aspects of hepatitis D virus infections.
    Dastgerdi ES; Herbers U; Tacke F
    World J Virol; 2012 Jun; 1(3):71-8. PubMed ID: 24175212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.
    Wu JC; Chen PJ; Kuo MY; Lee SD; Chen DS; Ting LP
    J Virol; 1991 Mar; 65(3):1099-104. PubMed ID: 1847439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future treatments for hepatitis delta virus infection.
    Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
    Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
    Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
    J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity
    Michelet M; Alfaiate D; Chardès B; Pons C; Faure-Dupuy S; Engleitner T; Farhat R; Riedl T; Legrand AF; Rad R; Rivoire M; Zoulim F; Heikenwälder M; Salvetti A; Durantel D; Lucifora J
    JHEP Rep; 2022 Mar; 4(3):100415. PubMed ID: 35141510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis delta virus: Replication and pathogenesis.
    Sureau C; Negro F
    J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N
    Kim GW; Moon JS; Gudima SO; Siddiqui A
    J Virol; 2022 Oct; 96(19):e0112422. PubMed ID: 36102650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D virus: an update.
    Pascarella S; Negro F
    Liver Int; 2011 Jan; 31(1):7-21. PubMed ID: 20880077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis delta: immunopathogenesis and clinical challenges.
    Grabowski J; Wedemeyer H
    Dig Dis; 2010; 28(1):133-8. PubMed ID: 20460901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on hepatitis D: From virology to new therapies.
    Mentha N; Clément S; Negro F; Alfaiate D
    J Adv Res; 2019 May; 17():3-15. PubMed ID: 31193285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between hepatitis B virus and delta virus.
    Shirvani-Dastgerdi E; Tacke F
    World J Virol; 2015 May; 4(2):36-41. PubMed ID: 25964870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.
    Freitas N; Cunha C; Menne S; Gudima SO
    J Virol; 2014 May; 88(10):5742-54. PubMed ID: 24623409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.